0001765883-19-000001.txt : 20190125 0001765883-19-000001.hdr.sgml : 20190125 20190124200416 ACCESSION NUMBER: 0001765883-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20190125 DATE AS OF CHANGE: 20190124 EFFECTIVENESS DATE: 20190125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CuraSen Therapeutics, Inc. CENTRAL INDEX KEY: 0001765883 IRS NUMBER: 812270808 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-331349 FILM NUMBER: 19541028 BUSINESS ADDRESS: STREET 1: 2655 CAMPUS DRIVE, SUITE 110 CITY: SAN MATEO STATE: CA ZIP: 94403 BUSINESS PHONE: (650) 475-2841 MAIL ADDRESS: STREET 1: 2655 CAMPUS DRIVE, SUITE 110 CITY: SAN MATEO STATE: CA ZIP: 94403 D 1 primary_doc.xml X0708 D LIVE 0001765883 CuraSen Therapeutics, Inc. 2655 CAMPUS DRIVE, SUITE 110 SAN MATEO CA CALIFORNIA 94403 (650) 475-2841 DELAWARE None None Corporation true 2016 Anthony P. Ford 2655 Campus Drive, Suite 110 San Mateo CA CALIFORNIA 94403 Executive Officer Director Kathleen Sereda Glaub 2655 Campus Drive, Suite 110 San Mateo CA CALIFORNIA 94403 Director Liam Ratcliffe 2655 Campus Drive, Suite 110 San Mateo CA CALIFORNIA 94403 Director Patrick Enright 2655 Campus Drive, Suite 110 San Mateo CA CALIFORNIA 94403 Director Henry Skinner 2655 Campus Drive, Suite 110 San Mateo CA CALIFORNIA 94403 Director Benjamin Potter c/o Latham & Watkins LLP 140 Scott Drive Menlo Park CA CALIFORNIA 94025 Executive Officer Biotechnology Decline to Disclose 06c false 2018-09-18 false true false 1 54499989 27249994 27249995 false 10 0 0 0 true false CuraSen Therapeutics, Inc. /s/Anthony P. Ford Anthony P. Ford President & CEO 2019-01-24